Milestone Scientific (NYSE:MLSS) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Milestone Scientific (NYSE:MLSS) in a research note released on Tuesday morning. The firm issued a hold rating on the stock.

Milestone Scientific Stock Performance

NYSE MLSS opened at $0.91 on Tuesday. The firm has a market cap of $70.73 million, a price-to-earnings ratio of -12.97 and a beta of 1.12. The firm has a 50 day simple moving average of $1.05 and a 200-day simple moving average of $0.96. Milestone Scientific has a one year low of $0.54 and a one year high of $1.39.

Institutional Trading of Milestone Scientific

A number of large investors have recently modified their holdings of MLSS. Y Intercept Hong Kong Ltd acquired a new stake in Milestone Scientific in the 3rd quarter valued at about $48,000. World Investment Advisors LLC acquired a new position in Milestone Scientific during the 3rd quarter worth approximately $91,000. Renaissance Technologies LLC increased its position in shares of Milestone Scientific by 72.8% in the 4th quarter. Renaissance Technologies LLC now owns 126,275 shares of the company’s stock valued at $121,000 after purchasing an additional 53,198 shares during the last quarter. Carnegie Investment Counsel raised its holdings in shares of Milestone Scientific by 18.9% in the 4th quarter. Carnegie Investment Counsel now owns 172,609 shares of the company’s stock valued at $166,000 after purchasing an additional 27,412 shares in the last quarter. Finally, Geode Capital Management LLC lifted its position in shares of Milestone Scientific by 6.4% during the 3rd quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after purchasing an additional 31,572 shares during the last quarter. Hedge funds and other institutional investors own 5.79% of the company’s stock.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.